A
Description
Apexcela is a Thai pharmaceutical company specializing in biosimilar products, operating as a subsidiary of Siam Bioscience. Its lead product is Hema-Plus (epoetin alfa) for anemia treatment, with a filgrastim biosimilar in its pipeline. The company is based in Bangkok's Pathumwan district.